GS0051: Nasal spray preparations; pharmaceutical preparations for the treatment of nervous system disorders and epileptic seizures and anxiety; pharmaceutical preparations, namely, pain relief medication; pharmaceutical preparations for the treatment of pain and conditions associated with pain and epileptic seizures, and anxiety; pharmaceutical preparations for the treatment of nervous system disorders, epileptic seizures and anxiety, pain, and conditions associated with pain sold in pre-filled medical apparatus and drug delivery devices
Case File Event Statements
4/12/2022 - 2 years ago
1 - NEW APPLICATION ENTEREDType:NWAP
4/13/2022 - 2 years ago
2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTEREDType:NWOS
1/25/2023 - a year ago
3 - ASSIGNED TO EXAMINERType:DOCK
1/26/2023 - a year ago
4 - APPROVED FOR PUB - PRINCIPAL REGISTERType:CNSA
2/28/2023 - a year ago
6 - PUBLISHED FOR OPPOSITIONType:PUBO
2/8/2023 - a year ago
5 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILEDType:NONP
2/28/2023 - a year ago
7 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILEDType:NPUB
4/25/2023 - a year ago
8 - NOA E-MAILED - SOU REQUIRED FROM APPLICANTType:NOAM
10/25/2023 - a year ago
12 - SOU EXTENSION 1 FILEDType:EXT1
10/25/2023 - a year ago
14 - USE AMENDMENT FILEDType:IUAF
10/25/2023 - a year ago
9 - TEAS STATEMENT OF USE RECEIVEDType:EISU
11/1/2023 - a year ago
11 - CASE ASSIGNED TO INTENT TO USE PARALEGALType:AITU
11/1/2023 - a year ago
13 - SOU EXTENSION 1 GRANTEDType:EX1G
11/1/2023 - a year ago
15 - STATEMENT OF USE PROCESSING COMPLETEType:SUPC
11/2/2023 - a year ago
19 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILEDType:EXRA
1/31/2024 - 11 months ago
20 - APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVEDType:XELR